ActivArmor offering is now closed and is no longer accepting investments.

Waterproof, Custom 3D Printed Casts and Splints

INVEST IN ACTIVARMOR TODAY!

At ActivArmor, we believe that everyone should be able to practice basic hygiene like showering and washing their hands, even if they have an injury. Our mission is to improve the safety and quality of life of the tens of thousands of people requiring immobilization worldwide, with waterproof, hygienic, custom-fitted casts and splints. We are a global company, with sales in 6 countries, having given lifestyle freedoms back to thousands of patients to date, and have hundreds of referring providers nationwide.
... Show more
This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
ActivArmor

Reasons to Invest


  • The casting and splinting market is expected to reach $4 billion by 2027 with a CAGR of 6.1% (source), and we believe ActivArmor is a market disruptor, with our custom, waterproof, sanitizable, hygienic 3D printed casts and splints.


  • Our goal is that our cutting-edge technology can advance the next generation of orthopedics, with the momentum and brand recognition as the leaders in the space, and the potential to revolutionize the way physicians treat fractures.


  • We have established IP (from 3D body mapping, through custom digital design software and 3D printing, with a clinically-tested product portfolio of waterproof, sanitizable immobilization, from on-demand custom-fittable trauma splints to our custom-designed wrist, hand, elbow, and foot casts and splints - available to ANY provider nationwide on iPhone. Can you imagine the international opportunity? 


OVERVIEW


ActivArmor is Changing the Face of Orthopedics


Everyone should have the right to basic hygiene and safety - even if you need to wear a cast or splint. We are global providers of sanitizable, clinically proven 3D printed casts, and with that, we aim to become the standard of care for immobilization worldwide. 


In addition to allowing patients to practice basic hygiene, our products allow patients to wash and sanitize their hands during a global pandemic.


The ability to see and treat the skin while staying immobilized reduces the chance of infection and complication rates. The breathable design, without moisture and bacteria-trapping fabric, reduces skin reactions, irritation, and breakdown. Not to mention the ability to adapt our product for use with bone and muscle stimulators, TENS units, and biomonitors that can improve healing outcomes, reduce healing and rehab times, and reduce opioid use.  The custom-design ensures a low-profile, lightweight, durable, protective, and comfortable cast for every patient’s unique body map.




One size does not fit all!




ActivArmor was established in 2014 by Diana Hall, a Colorado School of Mines graduate in Chemical Engineering.  She was running a mentoring program for children in poverty, who frequently had soggy, smelly, filthy casts after just weeks of care. Diana knew that there was a better alternative to casting and splinting through the use of additive manufacturing and biocompatible, sanitizable plastics. From this need for an innovative solution, ActivArmor was born.


The Problem


Traditional Casts are Not Washable or Sanitizable

Traditional fiberglass and plaster casts have to be kept clean and dry over weeks - but they tend to get smelly and sweaty and dirty, cause skin breakdown, and don’t allow you to practice basic hygiene like washing your hands and showering.  


ActivArmor waterproof, sanitizable casts allow patients to swim, bathe, shower, sweat, and live their normal active lifestyles while healing.



THE solution


Waterproof, Breathable, Sanitizable Custom Designed and Fitted Plastic Casts


Hygienic materials and breathable, custom-fit designs allow for improved healing and treatment options - not to mention freedom for the patients. 


ActivArmor is a support device custom fit to each patient’s unique body, mapped to the contours of the limb for injuries requiring stabilization and immobilization for healing. Used by orthopedic surgeons, PTs, OTs, athletic trainers, and hand therapists for acute injuries like fractures, for chronic conditions like Carpal Tunnel Syndrome, and for diabetic foot conditions, its custom designs make it versatile enough for a range of support applications.


Our portfolio includes the products and services:

  • Waterproof, adjustable, lockable trauma care splint 
  • Sanitizable, washable, custom-designed cast delivery service
  • Full in-clinic custom cast 3D printing package 


Our inventory on-demand trauma care splints (ideal for E.R., urgent care and military use) fit in 1 minute, are waterproof, washable, breathable, and adjustable for changes in swelling. They lock-on for compliance, are reusable, customizable and covered by insurance.



Our full-service custom-designed casts are provided to patients in four easy steps. 

  1. A 3-dimensional (3D) mapping of the injured limb (with iPhone) creates the exact fit for the client, and allows for custom exposures, coverage areas, and offsets.  
  2. The scan is sent to us via Secure Cloud for the custom design and fabrication production. 
  3. The cast is received in 3-4 days.
  4. The patient gets fitted for the custom cast by their physician or our experienced Ortho Technician via tele-health


Our in-clinic automated design and printing package gives providers the ability to fabricate custom-designed casts and splints, print them on-site while the patient waits.



Unlike traditional cast and immobilization methods, ActivArmor is custom fabricated using a high-temperature thermosetting plastic, yielding the unique ActivArmor immobilization device.

 

Here are some facts about our casts:

Our automated in-clinic fabrication package is currently slated for a Q4 release in 2022 - greatly speeding up the time for patients to receive their customized casts. Physicians can use their iPhone scan for the cast. After the scan, the custom design is created in moments and the device is printed on-site while the patient waits.


We have a business model similar to other successful custom-fit medical products that use direct-to-consumer marketing - but what makes us unique is our adoption by the orthopedic and fracture casting market.


Overall, our mature, dynamic business plan is founded on…


  • 2 years of Field Trials and 7 years of commercial sales
  • Over 40 active partnering hospitals and clinics today
  • Hundreds of referring physicians
  • Thousands of happy patients successfully and safely treated


THE Market


The Current Immobilization Market is Huge


The casting and splinting market size is poised to reach $4 billion by 2027 at a CAGR of 6.1% (source).


Not to mention, the additive manufacturing market is likely to reach $5.1 billion by 2026. The personalized medical solutions market, including personalized orthotics and prosthetics, is valued at approximately $10 billion (source). 

We are ideally positioned in the global marketplace, as 3D printing is poised to break into mainstream medicine. Custom wearable medical devices allow for improved comfort, and better adaptation for advanced healing technologies (source). 


g


Sanitizable, hygienic materials can improve healing outcomes and patient quality of life - and we believe our products will lead the charge in the orthopedic landscape.


Our Traction


A Proven Product with Proven Process


We are a global company with partners in 5 other countries so far, including Australia, South Africa, Canada, Kuwait, and Greece, with contracts pending in Egypt, Dubai, and the U.K. We fit professional athletes including NFL and NHL players, and have partnering clinics across the country including St. Luke's Medical Center, Children’s Hospital Colorado, Cornerstone Orthopaedics, ABQ Orthopaedics, Jacksonville Orthopedic Institute, Precision Orthopedics, and Sports Medicine, Orthopedics of Illinois, Central Indiana Orthopedics, Northeast Orthopedic Clinic, and Washington Orthopaedic Center, just to name a few.



We have fit thousands of patients and have hundreds of referring providers. And with that, we’ve experienced overwhelmingly positive healing outcomes and patient responses.

g


Lately, we’ve been improving our technology even further. In the last 8 months alone, we’ve successfully…


1. Established our new product line of Insta-Armor, waterproof trauma splints (product can be used for patients waiting for their custom cast)

2. Launched our new iPhone app that allows anyone nationwide to perform a 3D body scan and order custom devices (source)

3. Developed a hygienic, waterproof custom walking-boot, proven to offload and reduce infections and amputations in patients with Diabetic foot issues (source)

4. Expanded into multiple new cities and clinics nationwide (source)

5. Established partnerships and begun development of our automated in-clinic custom design and fabrication system


We have patents pending on the custom casts and the trauma splints,   licensed design software being automated, and trade secrets in the design and manufacturing processes.


Our future plans include partnering with clinics to provide in-clinic 3D printing services, reducing the 3-day turnaround for customized casts to just a few hours. We expect this service to become available later this year.


Why Invest


We Want to Change the Standard of Care for Immobilization Worldwide


By providing sanitizable immobilization devices to everyone - we can keep people safe by allowing them to practice basic hygiene.


With global expansion and further market penetration, we believe ActivArmor could, and should, be the standard of care for casting and splinting. 


We see ourselves growing sales, and then either go public, or sell to a company with the resources to help us grow more quickly. And in the meantime, we plan on spending this raise on marketing and sales of our new product line, including the launch of our in-clinic 3D printing package.


We believe we have the momentum and potential to lead in the market, and change the face of orthopedics. By investing in us, you are investing in bringing casting into the 21st Century and improving safety, hygiene, lifestyle freedoms, and patients’ quality of life while healing.



THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

ABOUT

HEADQUARTERS
2828 Granada Boulevard
Pueblo, CO 81005
VALUATION
$21.87M

At ActivArmor, we believe that everyone should be able to practice basic hygiene like showering and washing their hands, even if they have an injury. Our mission is to improve the safety and quality of life of the tens of thousands of people requiring immobilization worldwide, with waterproof, hygienic, custom-fitted casts and splints. We are a global company, with sales in 6 countries, having given lifestyle freedoms back to thousands of patients to date, and have hundreds of referring providers nationwide.

TEAM

Diana Hall
Diana Hall
Founder/President/CEO

Diana was named Colorado Manufacturing Woman of the year, and has won many awards including the Small Business of the Year award, the Southern Colorado Entrepreneurship Competition’s Social Entrepreneurship award, the regional InnovateHER competition, Nationwide Insurance’s national $100,000 Pitch To Win competition, and is listed as Top 100 Colorado Manufacturers. She has spoken at several venues on the topic of 3D design and printing, small business ownership and start-ups, economic development and entrepreneurship, and has given a TEDx talk on the future of mass customization in design and manufacturing in 2015.  

TERMS

ActivArmor
Overview
PRICE PER SHARE
$1.70
DEADLINE
Nov 4, 2022
VALUATION
$21.87M
AMOUNT RAISED
$332,031.24
Breakdown
MIN INVESTMENT
$170.00
MAX INVESTMENT
$4,999,999.20
MIN NUMBER OF SHARES OFFERED
5,882
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
2,941,176

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

ActivArmor, Inc.

Corporate Address

:

2828 Granada Boulevard, Pueblo, CO 81005

Offering Minimum

:

$9,999.40

Offering Maximum

:

$4,999,999.20

Minimum Investment Amount

(per investor)

:

$170.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

5,882

Maximum Number of Shares Offered

:

2,941,176

Price per Share

:

$1.70

Pre-Money Valuation

:

$21,868,919.00











Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives & Bonuses*

$500+ 

Mini-cast keychain set and ActivArmor auto decal

$1,000+ 

ActivArmor investor cap, mini-cast keychain set, and auto decal

$10,000+

ActivArmor plant tour in Pueblo, CO, ActivArmor investor cap, auto decal, and mini-cast keychain set

$50,000+

ActivArmor plant tour in Pueblo, CO followed by coffee with CEO, ActivArmor investor cap, auto decal, and mini keychain set

$100,000+

5% bonus shares, ActivArmor plant tour in Pueblo, CO followed by lunch with CEO, ActivArmor investor cap, auto decal, and mini keychain set

*All perks occur when the offering is completed.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested.


ALL UPDATES

10.27.22

ActivArmor Welcomes Maverick Foot and Ankle Specialists as Partnering Providers!

We are excited to welcome Maverick Foot and Ankle Specialists with locations in Las Colinas and South Irving, Texas!


Watch Us Grow!

10.26.22

Interview with our Founder in Voyage Denver

Check out an interview with ActivArmor Founder, Diana Hall, just published in Voyage Denver!

Hidden Gems: Meet Diana Hall of ActivArmor - VoyageDenver - Denver


10.25.22

We hit our $200k milestone!

We hit our $200,000 milestone, and

This is your LAST CHANCE to get a piece of the action!

Join us before it's too late!

10.20.22

Join our Founder/CEO for a live webinar Thursday 10/20!

✅ Major contract signed with Specialist GPO - Why is it such a big deal for investors & what's a Specialist GPO?

✅ Global & National growth - 10 countries & growing

✅ NFL - ActivArmor is contracted to work with NFL

✅ ActivArmor is an impact investment

✅ What's in-store for 2023 & beyond?


To register, just fill out the Contact form on our website at www.ActivArmor.com


Register Now for Thursday's Webinar! ..... This is an Ideal Opportunity for current & prospective investors on the last days of our crowdfunding campaign. As well as a Q&A session, you'll hear from Diana about her story/her why, the company mission and the future for ActivArmor both nationally and internationally. ActivArmor is an impact investment.


LESS THAN 16 Crowdfunding DAYS TO GO !!


Join us as we disrupt the traditional cast industry across the globe!


10.19.22

ActivArmor Chosen for Newchip’s Seed-Stage Global Accelerator Program

FOR IMMEDIATE RELEASE: 10/18/2022

Diana Hall

ActivArmor

719-821-0889

Diana.Hall@ActivArmor.com

 

ActivArmor Chosen for Newchip’s Seed-Stage Global Accelerator Program

 

3D printed casting company among top applicants selected for Newchip’s exclusive accelerator 

 

Pueblo, Colorado, 10/18/2022—ActivArmor, the global leader in sanitizable, waterproof immobilization devices for fracture and wound care, was accepted into Newchip’s renowned global accelerator program. Designed to provide all the skills and tools seed-stage founders need to rapidly fund, build and scale their companies, past accelerator cohorts averaged more than 17.5 times the average funding amount. The equity-free, fully digital accelerator has helped over 1,500 founders from more than 50 countries and 250 cities raise over $450 million in funding with an estimated portfolio of over $9 billion.

 

“Newchip evaluates a vast and diverse number of seed-stage companies from around the globe, selecting only a small percentage to be part of our Seed Accelerator program,” says Armando Vera Carvajal, Vice President of Product at Newchip. “This careful vetting process of both the business model and founder makes us an ideal partner for venture capital investors and other key stakeholders in early-stage startup financings who are looking for promising startups that are beginning to generate traction and revenue. Next-Gen biomedical companies like ActivArmor can scale quickly with proper funding and guidance. We are excited for ActivArmor and believe they will be well positioned to take advantage of our fast-expanding global ecosystem at Newchip.”

 

Launched in 2014, ActivArmor is on a mission to improve the safety and quality of life of those needing immobilization. Since launching the company has partnered with over 40 hospitals and clinics across the U.S. and in 10 other countries, and contracted with the workers comp provider for the NFL.  Thousands of patients have been successfully treated with ActivArmor casts, from hundreds of referring physicians and top orthopedic surgeons.

 

“Being part of the Newchip Accelerator, we are looking forward to introducing an on-site custom design and fabrication package that is affordable and easy enough to replace traditional casting and become the standard of care in orthopedics,” says Diana Hall, Founder of ActivArmor. “Our new business model will allow us to grow and scale at a much faster rate.”

 

                                                                        ###

About ActivArmor

ActivArmor is a global biomedical startup providing the only sanitizable 3D printed cast on the market, allowing patients to wash their hands during the Covid-19 global pandemic.  The high-tech casts are completely custom – precisely fitting to each patient using a body scan, and designed per the doctor’s prescription, including the ability to expose post-surgical hardware or incisions, and adaptable for use with ultrasound and other advanced technologies.  ActivArmor orthoses are being prescribed for injuries like breaks, sprains, Carpal Tunnel Syndrome, and Charcot Foot, through top orthopedic clinics across United States and in 10 other countries.  For an overview of the company: https://youtu.be/AcPN780Lpw0.  To learn more, visit www.ActivArmor.com.

 

         Text, logo

Description automatically generated                           See the source image

 

About Newchip

Newchip is an online, global startup accelerator led by a world-class team of entrepreneurs and investors. It was designed to provide founders with the tools needed to rapidly fund, build, and scale. Since its inception in 2019, the equity-free, remote accelerator has enabled over 1,500 startups from 50+ countries to raise over $450 million in funding with an estimated $9B portfolio. It has three distinct six-month accelerator programs based on company stage: Pre-Seed, Seed, and Series A. Its vast network of global investors, strategic partners, and mentors guide companies from team building and prototype development to securing high-profile VC investment, corporate partnerships, and everything in-between. To learn more, visit https://launch.newchip.com/.

10.18.22

ActivArmor Announces Contract with MediGroup GPO

ANNOUNCEMENT

ActivArmor has signed with MediGroup GPO, the single largest non-acute care group purchasing organization in the U.S.!




MediGroup has over 40,000 member clinics across the country!

What does this mean for investors?

  • ActivArmor is proving their commitment to growth strategy and potential
  • ActivArmor is showing large-scale demand by major market players
  • ActivArmor has tapped into a new distribution channel for major sales revenue growth above and beyond projections

Time is running out, join us today!



10.17.22

ActivArmor is a Minority-Owned Business!

Support a woman-owned tech startup and invest in the FUTURE!


10.12.22

Webinar and live Q&A with ActivArmor Founder and CEO tomorrow! Join us!

10.11.22

Time to own equity in ActivArmor is running out!


10.06.22

ActivArmor Welcomes 2 New Clinics as Providers!

A big welcome to our 2 new partnering clinics this week!

Watch us as we GROW!


#ToledoOhio #PuebloColorado #ActivArmor











REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into ActivArmor.

$500.00

$500+

Mini-cast keychain set and ActivArmor auto

$1,000.00

$1,000+

ActivArmor investor cap, mini-cast keychain set, and auto decal

$10,000.00

$10,000+

ActivArmor plant tour in Pueblo, CO, ActivArmor investor cap, auto decal, and mini-cast keychain set

$50,000.00

$50,000+

ActivArmor plant tour in Pueblo, CO followed by coffee with CEO, ActivArmor investor cap, auto decal, and mini keychain set

$100,000.00

$100,000+

5% bonus shares, ActivArmor plant tour in Pueblo, CO followed by lunch with CEO, ActivArmor investor cap, auto decal, and mini keychain set

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDSWe want you to succeed and get the most out of your money by offering rewards and memberships!
SECUREYour info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTSInvest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.